What the evidence says. For its approved parasitic uses ivermectin is strongly proven; for the marketed off-label claims, multiple large placebo-controlled trials and a Cochrane review show no meaningful COVID-19 benefit, and cancer evidence is limited to cell and animal studies. (No Evidence evidence: No credible human evidence supports the marketed claims — widely considered ineffective.)
⚠
Health warning. Ivermectin is an excellent prescription antiparasitic, but self-treating COVID-19 or cancer, especially with veterinary products, has caused confusion, seizures and hospitalisations, and must never replace or delay proven care.
What is Ivermectin (Off-label Use)?
Ivermectin (Off-label Use) (Avermectin antiparasitic) is a debunked supplement marketed for treats or prevents covid-19. NutriDex grades the human evidence as No Evidence. Ivermectin is a genuinely important medicine: its discoverers shared the 2015 Nobel Prize, and it is a first-line treatment for river blindness, strongyloidiasis, scabies and lice. This entry grades only the off-label claims. Early-pandemic lab work showed it inhibited SARS-CoV-2 at concentrations far above those reached with safe human doses, and small positive trials followed, some later found unreliable or fraudulent. Large, well-run randomised trials then found no meaningful benefit: TOGETHER (hospital or prolonged ER care 14.7% vs 16.3% on placebo), ACTIV-6 at both 400 and 600 µg/kg, COVID-OUT, and the UK PRINCIPLE trial (about 2 days faster self-reported recovery, but no difference in hospitalisation or 6-month recovery). A 2022 Cochrane review agreed. For cancer, activity has been shown only in cell and animal studies; no randomised human trial shows it treats any cancer. In 2025 Arkansas, Idaho, Louisiana and Texas joined Tennessee in letting adults obtain it from pharmacies without an individual prescription, a legal change rather than new evidence.
Marketed Claims (unproven)
✕(Claimed) treats or prevents COVID-19
✕(Claimed) cures or shrinks cancer
✕(Claimed) broad antiviral 'wonder drug'
✕(Proven, prescription) treats river blindness, strongyloidiasis, scabies and lice
Dosing & Compounds
Use & Legality
Approved human uses (such as strongyloidiasis, river blindness and scabies) are prescription-dosed by body weight by a clinician. There is no validated dose for COVID-19 or cancer. Never use veterinary pastes, drenches or injectables, which are far more concentrated.
Active Compounds
Ivermectin (22,23-dihydroavermectin B1a/B1b)Derived from avermectins of Streptomyces avermitilis
Safety & Cautions
⚠
At prescribed doses ivermectin is usually well tolerated, but overdoses, most often from veterinary pastes or injectables meant for horses and cattle, cause neurotoxicity (confusion, ataxia, seizures, coma), vomiting and low blood pressure, and US poison-centre calls surged in 2021. It can raise the INR in people on warfarin, and drugs that block P-glycoprotein or CYP3A4 can increase its levels. People heavily infected with the Loa loa parasite risk serious brain reactions, and it should be avoided in pregnancy unless prescribed. Taking it instead of vaccines, antivirals or cancer treatment is the largest harm. Educational only — always check with your doctor or pharmacist before combining Ivermectin (Off-label Use) with any medicine.
Ivermectin (Off-label Use) is most often marketed for (Claimed) treats or prevents COVID-19, (Claimed) cures or shrinks cancer, (Claimed) broad antiviral 'wonder drug', (Proven, prescription) treats river blindness, strongyloidiasis, scabies and lice. A Nobel-winning antiparasitic; large trials found no COVID-19 benefit.
Does Ivermectin (Off-label Use) work — what does the evidence say?
No Evidence evidence. No credible human evidence supports the marketed claims — widely considered ineffective. Ivermectin is a genuinely important medicine: its discoverers shared the 2015 Nobel Prize, and it is a first-line treatment for river blindness, strongyloidiasis, scabies and lice. This entry grades only the off-label claims. Early-pandemic lab work showed it inhibited SARS-CoV-2 at concentrations far above those reached with safe human doses, and small positive trials followed, some later found unreliable or fraudulent. Large, well-run randomised trials then found no meaningful benefit: TOGETHER (hospital or prolonged ER care 14.7% vs 16.3% on placebo), ACTIV-6 at both 400 and 600 µg/kg, COVID-OUT, and the UK PRINCIPLE trial (about 2 days faster self-reported recovery, but no difference in hospitalisation or 6-month recovery). A 2022 Cochrane review agreed. For cancer, activity has been shown only in cell and animal studies; no randomised human trial shows it treats any cancer. In 2025 Arkansas, Idaho, Louisiana and Texas joined Tennessee in letting adults obtain it from pharmacies without an individual prescription, a legal change rather than new evidence.
What is the typical dose of Ivermectin (Off-label Use)?
Approved human uses (such as strongyloidiasis, river blindness and scabies) are prescription-dosed by body weight by a clinician. There is no validated dose for COVID-19 or cancer. Never use veterinary pastes, drenches or injectables, which are far more concentrated.
Is Ivermectin (Off-label Use) safe? Any cautions or side effects?
At prescribed doses ivermectin is usually well tolerated, but overdoses, most often from veterinary pastes or injectables meant for horses and cattle, cause neurotoxicity (confusion, ataxia, seizures, coma), vomiting and low blood pressure, and US poison-centre calls surged in 2021. It can raise the INR in people on warfarin, and drugs that block P-glycoprotein or CYP3A4 can increase its levels. People heavily infected with the Loa loa parasite risk serious brain reactions, and it should be avoided in pregnancy unless prescribed. Taking it instead of vaccines, antivirals or cancer treatment is the largest harm.
How many studies support Ivermectin (Off-label Use)?
NutriDex cites 10 sources for Ivermectin (Off-label Use), graded "No Evidence".
Cite this page
APA
Peh, D. (2026). Ivermectin (Off-label Use) (Avermectin antiparasitic): Benefits, Dosage, Side Effects & Evidence. NutriDex — The Supplement Research Compendium. Retrieved 18 Oct 2026, from https://nutridex.info/s/ivermectin
BibTeX
@misc{nutridex_ivermectin,
author = {Peh, Daryl},
title = {Ivermectin (Off-label Use) (Avermectin antiparasitic): Benefits, Dosage, Side Effects \& Evidence},
year = {2026},
howpublished = {NutriDex --- The Supplement Research Compendium},
url = {https://nutridex.info/s/ivermectin},
note = {Reviewed by Dr Daryl Peh, MBBS Singapore, MMed FM. Accessed 2026-10-18}
}
For medical claims, citing the underlying primary studies linked above is preferred. NutriDex is an educational reference, not medical advice.